Facebook-f X-twitter Linkedin-in Instagram Podcast

Thoracic Oncology Group of Australasia

Podcasts

Listen to TOGA’s podcast on the latest treatments and topics in lung cancer and mesothelioma. Hosted by a variety of experts to bring together a multidisciplinary and collaborative perspective.

TOGA Podcast Series

75 – The Evolving Landscape of ROS1-positive NSCLC
  • Podcasts
Host A/Prof Steven Kao is joined by A/Prof Venessa Chin and Dr Ben Kong,
74 – Prof Zarnie Lwin OAM: Mentorship, Research, and the Future of Lung Cancer Treatment
  • Podcasts
Host A/Prof Mel Moore interviews Prof Zarnie Lwin OAM, University of Queensland; Medical Oncologist at Royal Brisbane and Women’s Hospital and The Prince Charles Hospital.
73 – Smoking Stigma and Lung Cancer Care in the Screening Era
  • Podcasts
A/Prof Gavin Wright sits down with a multidisciplinary panel of experts to tackle the critical and complex issue of smoking-related stigma in lung cancer.
72 – Dr Jazmin Eckhaus: Robotic Innovations and Ethics in Thoracic Surgery
  • Podcasts
Host A/Prof Mel Moore interviews Dr Jazmin Eckhaus, a practising surgeon in the subspecialty of thoracic surgery.
71 – Immunotherapy in Thoracic Cancers: Applying Broad IO Access Across Thoracic Malignancies
  • Podcasts
Host A/Prof Adnan Nagrial leads a panel discussing the clinical implications of the broad PBS listing of ipilimumab and nivolumab in Australia.
70 – Immunotherapy in Thoracic Cancers: From Indication-Based to Biology-Driven
  • Podcasts
Host A/Prof Deme Karikios leads a panel discussion focusing on the recent, groundbreaking broad PBS listing of certain immunotherapy agents in Australia.
69 – The Evolving Landscape of BRAF-Mutated NSCLC in Australia
  • Podcasts
Host A/Prof Rachel Roberts-Thomson leads a panel discussion focusing on the landscape of BRAF-mutated non-small cell lung cancer.
68 – Thymic Cancer: The Lesser-Known Thoracic Tumours
  • Podcasts
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Malinda Itchins, a medical oncologist and clinician researcher at Royal North Shore Hospital
67 – A/Prof Surein Arulananda: A Masterclass in Career Growth
  • Podcasts
In this episode, we welcome A/Prof Surein Arulananda, the interim Director of Medical Oncology and Thoracic Oncology Trials Lead at Monash Health.
66 – TOGA ASM 2026: Program Review
  • Podcasts
In this episode, we welcome A/Prof Surein Arulananda, Dr Archit Chawla, Dr Renae Grundy, and Dr Neil Wallace.
65 – ALK TKI Sequencing in the Australian Landscape
  • Podcasts
In this episode, we welcome A/Prof Tim Clay, Prof Ben Solomon and A/Prof Malinda Itchins
64 – Prof Michael Millward: Clinical Insights in Lung Cancer Research
  • Podcasts
In this episode, we welcome Prof Michael Millward.
63 – Dr Megan Sanders: From Science to TOGA Leadership
  • Podcasts
In this episode, we welcome Dr Megan Sanders, CEO of the Thoracic Oncology Group of Australasia.
62 – Lung Cancer Research: 2025 Year in Review
  • Podcasts
In this episode, a multidisciplinary panel unpacks the latest progress and emerging priorities in lung cancer research across Australia and New Zealand.
61 – New and Emerging Practice Standards in ES-SCLC
  • Podcasts
In this episode, the focus is on the latest developments in small cell lung cancer treatment.
Lung cancer podcast- lung cancer care and research in New Zealand
60 – Exploring Lung Cancer Care and Research in New Zealand
  • Podcasts
In this episode, the focus is on the current state of lung cancer care and research in New Zealand.
Lung cancer podcast Challenging Ageism: Optimising Lung Cancer Treatment in Older Adults with Dr Michael Krasovitsky, A/Professor Christopher Steer, Professor Shalini Vinod, and Ms. Nicole Webb.
59 – Challenging Ageism: Optimising Lung Cancer Treatment in Older Adults
  • Podcasts
In this episode, the focus is on cancer care in older adults and the application of geriatric oncology.
Lung cancer podcast with Prof Anna Nowak
58 – Prof Anna Nowak: A Journey from Oncology Lab to Leadership
  • Podcasts
In this episode, we welcome Prof Anna Nowak, a renowned medical oncologist, clinical trialist, and tumour immunology researcher.
Lung cancer podcast- brain metastases and central nervous system (CNS) progression. with Tim Clay
57 – CNS Progression in Lung Cancer – A Practical Conversation on Best Practices
  • Podcasts
In this episode, A/Prof Tim Clay, Dr Keryn Davidson and A/Prof Fiona Hegi-Johnson discuss the multidisciplinary management of CNS metastases in the context of thoracic
Lung cancer podcast A professional portrait of A/Prof. Fiona Hegi-Johnson, a woman with dark hair and a calm expression. Below the photo, the text reads "56: A Conversation with A/Prof. Fiona Hegi-Johnson." The logo for "Conversations in Lung Cancer Research" is also displayed.
56 – A/Prof Fiona Hegi Johnson: Navigating Careers and Innovations in Lung Cancer Research
  • Podcasts
In this episode, we welcome A/Prof Fiona Hegi Johnson, a radiation oncologist at the Peter McCallum Cancer Center and senior research fellow at the University
Lung cancer podcast with Shankar Siva
55 – Prof Shankar Siva: Pushing Boundaries in Radiation Oncology
  • Podcasts
In this episode, we welcome Prof Shankar Siva, a leading Radiation Oncologist.
Images of Dr Anna McLean, Dr Mark Adams, and Dr Sagun Parak Text: The Emerging Role of the Microbiome in Lung Cancer and Immunotherapy Response
54 – The Emerging Role of the Microbiome in Lung Cancer and Immunotherapy Response
  • Podcasts
In this episode features Dr. Anna McLean, Dr Mark Adams, and Dr Sagun Parakh, discussing research on the microbiome and its influence on lung cancer
Listen to a lung cancer podcast with Bryan Chan
53 – A/Prof Bryan Chan: Lessons from Fellowships and building Clinical Trials Units
  • Podcasts
In this episode, we welcome A/Prof Bryan Chan, a senior Medical Oncologist and this years TOGA ASM Convener.
52 – Prof Wendy Cooper: Journey of a Thoracic Pathologist
  • Podcasts
In this episode, we chat with Prof Wendy Cooper, a leading pathologist in cancer research.
Prof Tom John Prof Georgina Long AO Prof Ken O'Byrne
51 – Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy
  • Podcasts
In this episode, Prof Tom John, Prof Georgina Long AO, and Prof Ken O'Byrne delve into technological advances spurred by COVID-19 vaccine development, promising results
50 – The Role of Liquid Biopsy in Modern Oncology
  • Podcasts
In this episode, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Steven Kao discuss the concept of liquid biopsy, its advantages and limitations, and its
Headshots of A/Prof Surein Arulananda, A/Prof Mel Moore, Dr. Malinda Itchins. 49 Exploring EGFR Exon 20 Insertion Mutations
49 – Exploring EGFR Exon 20 Insertion Mutations
  • Podcasts
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda, delve into
Conversations in Lung Cancer Research - Michael Boyer
48 – A Conversation with Prof. Michael Boyer
  • Podcasts
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and
Text Conversations in Lung Cancer on Blue background and TOGA logo
47 – Introducing Conversations in Lung Cancer Research
  • Podcasts
In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'
46 – Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy
  • Podcasts
Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC
45 – The Case For IO in Early-Stage NSCLC in a Once in a Lifetime World
  • Podcasts
Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.
44 – LCNEC Challenges in Diagnosis and Treatment
  • Podcasts
A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.
43 – Management of Limited-Stage Small Cell Lung Cancer
  • Podcasts
We dive into the latest survival data from the ADRIATIC trial, as presented at ASCO 2024, which could change the treatment landscape for LS-SCLC. Joining
42 – NTRK 1, 2, 3 and Other Rare Mutations in NSCLC
  • Podcasts
This episode is hosted by: A/Prof Steven Kao, Prof Wendy Cooper, and Prof Ben Solomon
41 – Decoding Perioperative Immunotherapy In NSCLC
  • Podcasts
This episode is hosted by: Dr Pei Ni Ding, Dr Samantha Bowyer, and Mr Naveed Alam.
40 – Access to New Medicines: Which Surrogate Endpoints Matter
  • Podcasts
This episode is hosted by: Dr Rebecca Tay, Professor Nick Pavlakis, and Dr Deme Karikios.
39 – Lung Cancer Nurses: Essential, Beneficial, and a Key Link in Lung Cancer Screening
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: Dr Vanessa Brunelli, Fiorina Gibbons, Melissa Laan and Associate Professor Henry Marshall
38 – Underutilisation of Radiotherapy in Lung Cancer Treatment
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: Professor Shalini Vinod, Assoc Professor Mei-Ling Yap and Dr Clare Bajraszewski
37 – Revolutionising lung cancer healthcare with A.I: Unlocking the future
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Michael Franco, Professor Catherine Jones and Dr Diane Pascoe
Tile for TOGA podcasts series episode on ADCs
36 – Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: A/Prof Melissa Moore, A/Prof Tom John and A/Prof Adnan Nagrial
35 – Lung cancer Screening and Moving from Concept to Roll Out
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: A/Prof Emily Stone and joined by A/Prof Gavin Wright, A/Prof Nicole Rankin and A/Prof Annette McWilliams
34 – Early Recovery After Surgery – Guidelines and Multidisciplinary Considerations
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: Dr Jazmin Eckhaus and joined by A/Prof Emily Stone, A/Prof Melissa Moore and Professor Catherine Granger.
33 – Nature and nurture: lung cancer risk and implications for future screening
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Tom John and joined by Professor Charles Swanton, Associate Professor Venessa Chin and Dr Tracy
32 – Operability in Stage III NSCLC
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: A/Professor Tim Clay and joined by Professor Lucy Morgan, A/Professor Phillip Antippa and also Dr Qurrat van
31 – NSCLC and KRAS Mutations
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Chee Lee joined by Dr Tristan Barnes and Dr Alex Davis.
30 – Treatment Considerations in ALK-Positive NSCLC
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: Dr Jenny Lee joined by Professor Nick Pavlakis and Lisa Briggs.
29 – Celebrating Female Leadership in Medical Research
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Prunella Blinman joined by Assistant Professor Narjust Florez, Professor Lorraine Chantrill and Dr Rebecca Tay.
28 – Brain metastases in NSCLC
  • Podcasts
Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Paul Mitchell, joined by Dr Fiona Hegi-Johnson and Dr Dasantha Jayamanne.
27 – NGS panels in lung cancer
  • Podcasts
In this episode, Dr Malinda Itchins is joined by Professor Stephen Fox, and Professor Michael Millward to discuss NGS panels in lung cancer.
26 – Lung Cancer Screening and its impact on patient care in Australia
  • Podcasts
A/Prof Gavin Wright discusses Lung Cancer Screening Program and its impact on patient care in Australia. He is joined by A/Prof Emily Stone, A/Prof Nicole
25 – The Management of Stage III NSCLC
  • Podcasts
Prof Shankar Siva, A/Prof Rachel Wong and Prof Drew Moghanaki discuss what defines inoperable NSCLC, patient selection and how to manage the toxicities associated with
24 – The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations
  • Podcasts
A/Prof Melissa Moore is joined by Dr Katharine See and Dr Naveed Alam to discuss and review the findings and implications for NSCLC patients.
23 – Cardiotoxicity and Radiation Therapy – Considerations for Lung Cancer
  • Podcasts
22 – Accelerating Progress in Oncogene-driven Lung Cancer
  • Podcasts
Dr Deme Karikios, Dr Wanda Cui and A/Prof Chris Karapetis discuss the advances in oncogene-driven lung cancer and what this means for trial design, patients
21 – Access to Molecular Diagnostics and Treatments Across ANZ: The Past, Present, Future
  • Podcasts
20 – Practical smoking cessation advice for health care providers
  • Podcasts
In this episode, we discuss smoking cessation in the face of smoking-related stigma and nihilism. Dr Henry Marshall, Prof Christine Paul and Dr Matt Steliga
19 – Consider Every Trial as a TeleTrial
  • Podcasts
A/Prof Craig Underhill, Prof Sabe Sabesan and patient advocate Alexandra Golledge discuss how TeleTrials bring new therapies to patients sooner to positively impact the future
18 – EGFR Update: Improving Outcomes in EGFR-Mutated Non-Small-Cell Cancer
  • Podcasts
A/Prof Rachel Roberts-Thomson, A/Prof Venessa Chin and Angeline Low discuss improving outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer.
17 – The need for a National Clinical Quality Registry in Lung Cancer
  • Podcasts
In this episode, Respiratory Physicians Prof Emily Stone , Prof Rob Stirling and Prof Fraser Brims discuss the need for funding for a national quality
16 – ALK treatment considerations in NSCLC
  • Podcasts
In this episode, we discuss ALK therapy choices and considerations when treating ALK NSCLC. Dr Malinda is joined by A/Prof Steven Kao and Lisa Briggs
15 – Stigma and Nihilism In Lung Cancer : A Call to Action
  • Podcasts
In recognising Lung Cancer Awareness 2021, A/Prof Melissa Moore, Briony Scott, Prof Suzanne Chambers and Prof Stewart Dunn,discuss the importance of treating lung cancer patients
14 – Challenging the Lung Cancer Stigma
  • Podcasts
Briony Scott discusses the stigma often associated with a diagnosis of lung cancer with Danielle and Terri – both diagnosed with lung cancer and managing
13 – The Value of Comprehensive Genomic Profiling in Lung Cancer
  • Podcasts
In this episode, Prof Nick Pavlakis and Prof Stephen Fox discuss Next-generation sequencing (NGS) based tumour comprehensive genomic profiling (CGP) that detects a wide range
12 – Inflammation And Its Impact On The Development & Treatment Of Lung Cancer
  • Podcasts
Prof Stephen Clarke and A/Prof Kellie Charles, the team that discovered that cancer-related inflammation altered chemotherapy pharmacokinetics, toxicity and survival, come together to discuss the
11 – Optimising Diagnosis & Treatment Pathways For Lung Cancer Patients
  • Podcasts
In this episode we discuss how delays in diagnosis are one of the main factors associated with reduced survival rates and how we can improve
10 – Long Term Survivorship: Thriving with Metastatic Lung Cancer
  • Podcasts
In this episode, Lillian Leigh, Dr Sarah Heynemann and Mary Duffy discuss the challenges associated with long term survivorship.
9 – Women and Lung Cancer: The Rising Tide
  • Podcasts
A/Prof Melissa Moore and Prof Lucy Morgan discuss the increase in lung cancer diagnoses for young women who have never smoked before.
8 – Practical Perspectives: Shifting the Needle in Small Cell Lung Cancer
  • Podcasts
7 – Lung cancer screening works!
  • Podcasts
In this episode, Prof Emily Stone and Prof Kwun Fong, both long time advocates and researchers in early screening discuss the challenges of implementing a
6 – Dreaming of Better Treatments for Mesothelioma
  • Podcasts
In this episode, Prof Anna Nowak and A/Prof Steven Kao discuss the emerging treatments for mesothelioma patients and the DREAM3R trial.
5 – Lung Cancer Careers: Preceptorship Reflections
  • Podcasts
A fireside chat with Prunella Blinman, Shankar Siva and our three Preceptees: Anna Lawless, Abhijit Pal and Melanie Rabbets about their experiences, their learnings, what
4 – Cancer won’t wait: A Cancer Australia Perspective
  • Podcasts
Dorothy Keefe, CEO of Cancer Australia and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients.
3 – 2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer
  • Podcasts
Prof Nick Pavlakis and Prof Emily Stone join discuss the remarkable advances in screening, diagnosing and treating lung cancer that occurred during 2020.
2 – Redefining Survival In Lung Cancer: Meet Alexandra
  • Podcasts
In this Podcast, Mark Scott talks with Alexandra Golledge about her challenges in diagnosis, searching for the best treatments available, living in a regional area
1- Improving Survival In Oncogene Driven Lung Cancer
  • Podcasts
A conversation with Associate Professor Tom John and Professor Ben Solomon where they discuss the increased survival benefits for patients with oncogene driven lung cancer
Join our community – stay up to date with the latest research, TOGA news and events

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Contact

PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198

Facebook-f X-twitter Linkedin-in Instagram Podcast
TOGA
Quicklinks
TOGA is an ACNC Registered Charity

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.

Copyright © 2026 TOGA – Thoracic Oncology Group Australasia. No part of this site may be reproduced without our written permission.